表紙
市場調查報告書
商品編碼
998442

敗血症診斷的全球市場:按產品,技術,病原體,測試類型,預測(∼2025年),COVID-19的累積影響進行的市場研究

Sepsis Diagnostic Market Research Report by Product, by Technology, by Pathogen, by Testing Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球膿毒症診斷市場預計將從2020年的4.285億美元增長到2025年底的6.695億美元。

市場細分和覆蓋範圍:

該研究報告對敗血症診斷的全球市場進行了分類,預測了收入,並分析了以下每個子市場的趨勢:

  • 就產品而言,市場遍及化驗試劑盒和試劑,血液培養基,儀器和軟件。分析試劑盒和試劑已在流式細胞儀,免疫分析,微生物學和分子診斷學領域得到了進一步的研究。血液培養基已通過流式細胞儀,免疫測定,微生物學和分子診斷學得到了進一步研究。對該儀器進行了流式細胞術,免疫測定,微生物學和分子診斷的進一步研究。該軟件已在流式細胞儀,免疫測定,微生物學和分子診斷學上得到了進一步的研究。 通過技術,在流式細胞儀,免疫測定,微生物學和分子診斷學領域開拓了市場。 [li]通過病原體,對細菌和真菌敗血症的市場進行了調查。對革蘭氏陰性和革蘭氏陽性細菌的細菌敗血症進行了進一步研究。
  • 根據測試類型,對實驗室和PoC測試進行了市場調查。
  • 按地區,對美洲,亞太地區以及歐洲和中東/非洲的市場進行了調查。美洲是阿根廷,巴西,加拿大,墨西哥和美國。亞太地區是澳大利亞,中國,印度,印度尼西亞,日本,馬來西亞,菲律賓,韓國和泰國。在法國,德國,意大利,荷蘭,卡塔爾,俄羅斯,沙特阿拉伯,南非,西班牙,阿拉伯聯合酋長國和英國對歐洲以及中東和非洲地區進行了調查。

企業可用性配置文件:

此報告包括Abbott實驗室,Alifax Srl,Alpa實驗室有限公司,Amara Health Analytics公司,Axis-Shield診斷公司,Beckman Coulter公司,Becton,Dickinson and Company,bioMerieux SA,Boditech Med,Bruker Corporation,Cerner公司,CytoSorbents公司,Danaher公司,EKF診斷公司,Epic Systems公司,F. Hoffmann-La Roche AG,GE Healthcare,GenMark診斷公司,Immunexpress Inc.,Koninklijke Philips NV,Luminex公司,McKesson公司,Response Biomedical Corporation,SEEGENE, Inc.,Thermo Fisher Scientific,Inc.,Wolters Kluwer NV和全球市場上的其他主要供應商已經探索了近期的重要發展和創新概況。

COVID-19的累積影響:

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了有關COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

該報告調查了敗血症診斷的全球市場,市場概況,市場增長和抑制因素的分析,市場機會,COVID-19的影響,產品技術,病原體,檢測類型,它提供了系統的信息,例如作為區域市場規模的趨勢和預測,競爭條件以及主要公司的概況。

360iResearch(TM)FPNV定位矩陣:

360iResearch(TM)FPNV定位矩陣提供業務戰略(業務增長,行業覆蓋範圍,財務可行性,渠道支持),以幫助公司做出更好的決策並瞭解其競爭格局,並根據產品滿意度對市場中的供應商進行評估和分類(性價比,易用性,產品功能和客戶支持)。

360iResearch(TM)競爭戰略窗口:

360iResearch(TM)競爭戰略窗口從市場,應用和區域角度分析競爭條件。這有助於供應商定義能力和機會之間的協調或適應,以實現未來的增長前景。在預測期內,供應商將採用持續的併購策略,區域擴展,研發和新產品實施策略,以最佳或有利地適應進一步的業務擴展和增長。

此報告提供有關以下準則的見解:

  • 1.市場滲透率:主要參與者提供的全面市場信息
  • 2.市場開發:有利可圖的新興市場的詳細信息和市場分析
  • 3.市場多元化:有關新產品發佈,欠發達地區,最新發展和投資的更多信息
  • 4.競爭評估和情報:全面評估主要公司的市場份額,戰略,產品和製造能力
  • 5.產品開發和創新:對未來技術,研發活動和新產品開發的智能見解

此報告回答以下問題

  • 1. 全球市場的規模和預測是多少?
  • 2. 在預測期內,構成市場的COVID-19有哪些障礙和影響?
  • 3. 在預測期內,您將投資哪些產品,細分,應用或領域?
  • 4. 市場機會的競爭性戰略窗口是什麼?
  • 5. 市場的技術趨勢和監管框架是什麼?
  • 6. 您認為適合進入市場的方式和戰略舉措是什麼?

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 考慮調查的年份
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 產品展望
  • 測試類型展望
  • 病原學展望
  • 技術展望
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察力

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 搬運工五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按產品

  • 分析試劑盒和試劑
    • 流式細胞儀
    • 免疫學檢查
    • 微生物學
    • 分子診斷
  • 血液培養基
    • 流式細胞儀
    • 免疫學檢查
    • 微生物學
    • 分子診斷
  • 設備
    • 流式細胞儀
    • 免疫學檢查
    • 微生物學
    • 分子診斷
  • 軟件
    • 流式細胞儀
    • 免疫學檢查
    • 微生物學
    • 分子診斷

技術第7章

  • 流式細胞儀
  • 免疫學檢查
  • 微生物學
  • 分子診斷

第8章,病原體

  • 細菌性敗血症
    • 革蘭氏陰性菌
    • 革蘭氏陽性細菌
  • 真菌性敗血症

第9章,按測試類型

  • 實驗室測試
  • PoC測試

第10章美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章歐洲,中東/非洲

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 衝突情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第14章企業可用性概況

  • Abbott Laboratories
  • Alifax S.r.l.
  • Alpa Laboratories Ltd
  • Amara Health Analytics, Inc.
  • Axis-Shield Diagnostics
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boditech Med
  • Bruker Corporation
  • Cerner Corporation
  • CytoSorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics
  • Epic Systems Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • GenMark Diagnostics
  • Immunexpress Inc.
  • Koninklijke Philips N.V.
  • Luminex Corporation
  • McKesson Corporation
  • Response Biomedical Corporation
  • SEEGENE, Inc
  • Thermo Fisher Scientific, Inc.
  • Wolters Kluwer N.V.

第15章附錄

  • 討論指南
  • 許可證和價格
目錄
Product Code: MRR-A339DAEFABB5

The Global Sepsis Diagnostic Market size was estimated at USD 421.85 Million in 2020 and expected to reach USD 461.62 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.76% to reach USD 737.89 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Sepsis Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Sepsis Diagnostic Market was studied across Assay Kits and Reagents, Blood Culture Media, Instruments, and Software. The Assay Kits and Reagents is further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Blood Culture Media is further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Instruments is further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics. The Software is further studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.

Based on Technology, the Sepsis Diagnostic Market was studied across Flow Cytometry, Immunoassays, Microbiology, and Molecular Diagnostics.

Based on Pathogen, the Sepsis Diagnostic Market was studied across Bacterial Sepsis and Fungal Sepsis. The Bacterial Sepsis is further studied across Gram-Negative Bacteria and Gram-Positive Bacteria.

Based on Testing Type, the Sepsis Diagnostic Market was studied across Laboratory Testing and PoC Testing.

Based on Geography, the Sepsis Diagnostic Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Sepsis Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Sepsis Diagnostic Market, including Abbott Laboratories, Alifax S.r.l., Alpa Laboratories Ltd, Amara Health Analytics, Inc., Axis-Shield Diagnostics, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMerieux SA, Boditech Med, Bruker Corporation, Cerner Corporation, CytoSorbents Corporation, Danaher Corporation, EKF Diagnostics, Epic Systems Corporation, F. Hoffmann-La Roche AG, GE Healthcare, GenMark Diagnostics, Immunexpress Inc., Koninklijke Philips N.V., Luminex Corporation, McKesson Corporation, Response Biomedical Corporation, SEEGENE, Inc, Thermo Fisher Scientific, Inc., and Wolters Kluwer N.V..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Sepsis Diagnostic Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sepsis Diagnostic Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sepsis Diagnostic Market?
  • 4. What is the competitive strategic window for opportunities in the Global Sepsis Diagnostic Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Sepsis Diagnostic Market?
  • 6. What is the market share of the leading vendors in the Global Sepsis Diagnostic Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Sepsis Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Testing Type Outlook
  • 3.5. Pathogen Outlook
  • 3.6. Technology Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences and prevalence of sepsis
      • 5.1.1.2. Growing occurrence of hospital-derived infections
      • 5.1.1.3. Development of technologically advanced diagnostic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive automated diagnostic services and dearth of reimbursement situations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging development of rapid diagnostics globally
      • 5.1.3.2. Development on novel biomarkers for sepsis diagnostics
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and standard protocols for the procedure
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Sepsis Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Assay Kits and Reagents
    • 6.2.1. Flow Cytometry
    • 6.2.2. Immunoassays
    • 6.2.3. Microbiology
    • 6.2.4. Molecular Diagnostics
  • 6.3. Blood Culture Media
    • 6.3.1. Flow Cytometry
    • 6.3.2. Immunoassays
    • 6.3.3. Microbiology
    • 6.3.4. Molecular Diagnostics
  • 6.4. Instruments
    • 6.4.1. Flow Cytometry
    • 6.4.2. Immunoassays
    • 6.4.3. Microbiology
    • 6.4.4. Molecular Diagnostics
  • 6.5. Software
    • 6.5.1. Flow Cytometry
    • 6.5.2. Immunoassays
    • 6.5.3. Microbiology
    • 6.5.4. Molecular Diagnostics

7. Sepsis Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. Flow Cytometry
  • 7.3. Immunoassays
  • 7.4. Microbiology
  • 7.5. Molecular Diagnostics

8. Sepsis Diagnostic Market, by Pathogen

  • 8.1. Introduction
  • 8.2. Bacterial Sepsis
    • 8.2.1. Gram-Negative Bacteria
    • 8.2.2. Gram-Positive Bacteria
  • 8.3. Fungal Sepsis

9. Sepsis Diagnostic Market, by Testing Type

  • 9.1. Introduction
  • 9.2. Laboratory Testing
  • 9.3. PoC Testing

10. Americas Sepsis Diagnostic Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States
    • 10.6.1. California
    • 10.6.2. Florida
    • 10.6.3. Illinois
    • 10.6.4. New York
    • 10.6.5. Ohio
    • 10.6.6. Pennsylvania
    • 10.6.7. Texas

11. Asia-Pacific Sepsis Diagnostic Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Sepsis Diagnostic Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Market Share Analysis, By Company
  • 13.5. Competitive Scenario
    • 13.5.1. Merger & Acquisition
    • 13.5.2. Agreement, Collaboration, & Partnership
    • 13.5.3. New Product Launch & Enhancement
    • 13.5.4. Investment & Funding
    • 13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbott Laboratories
  • 14.2. Alifax S.r.l.
  • 14.3. Alpa Laboratories Ltd
  • 14.4. Amara Health Analytics, Inc.
  • 14.5. Axis-Shield Diagnostics
  • 14.6. Beckman Coulter, Inc.
  • 14.7. Becton, Dickinson and Company
  • 14.8. bioMerieux SA
  • 14.9. Boditech Med
  • 14.10. Bruker Corporation
  • 14.11. Cerner Corporation
  • 14.12. CytoSorbents Corporation
  • 14.13. Danaher Corporation
  • 14.14. EKF Diagnostics
  • 14.15. Epic Systems Corporation
  • 14.16. F. Hoffmann-La Roche AG
  • 14.17. GE Healthcare
  • 14.18. GenMark Diagnostics
  • 14.19. Immunexpress Inc.
  • 14.20. Koninklijke Philips N.V.
  • 14.21. Luminex Corporation
  • 14.22. McKesson Corporation
  • 14.23. Response Biomedical Corporation
  • 14.24. SEEGENE, Inc
  • 14.25. Thermo Fisher Scientific, Inc.
  • 14.26. Wolters Kluwer N.V.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 51. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 53. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 55. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 60. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
  • FIGURE 62. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2020 VS 2026 (%)
  • FIGURE 64. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2026
  • FIGURE 66. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 68. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 70. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, 2018-2026 (USD MILLION)
  • FIGURE 71. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 72. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, 2018-2026 (USD MILLION)
  • FIGURE 73. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 74. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2020 VS 2026 (%)
  • FIGURE 75. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2026
  • FIGURE 77. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, 2018-2026 (USD MILLION)
  • FIGURE 78. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 79. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, 2018-2026 (USD MILLION)
  • FIGURE 80. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 81. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 82. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 83. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 84. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 87. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 88. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. CALIFORNIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. FLORIDA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. ILLINOIS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. NEW YORK SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. OHIO SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. PENNSYLVANIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 95. TEXAS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 96. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 97. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 98. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 99. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 100. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 101. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 102. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 103. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 104. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 105. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 106. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 107. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 108. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 109. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 110. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 111. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 112. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 113. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 114. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 115. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 116. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 117. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 118. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 119. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 120. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 121. GLOBAL SEPSIS DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
  • FIGURE 122. GLOBAL SEPSIS DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 123. GLOBAL SEPSIS DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 124. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SEPSIS DIAGNOSTIC MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SEPSIS DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY ASSAY KITS AND REAGENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BLOOD CULTURE MEDIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY IMMUNOASSAYS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY BACTERIAL SEPSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-NEGATIVE BACTERIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GRAM-POSITIVE BACTERIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY FUNGAL SEPSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY LABORATORY TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY POC TESTING, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. AMERICAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ARGENTINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. BRAZIL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. CANADA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. MEXICO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CALIFORNIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CALIFORNIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CALIFORNIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CALIFORNIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. FLORIDA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. FLORIDA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. FLORIDA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. FLORIDA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. ILLINOIS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. ILLINOIS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. ILLINOIS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. ILLINOIS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. NEW YORK SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. NEW YORK SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. NEW YORK SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. NEW YORK SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. OHIO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. OHIO SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. OHIO SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. OHIO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. PENNSYLVANIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. PENNSYLVANIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. PENNSYLVANIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. PENNSYLVANIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. TEXAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. TEXAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. TEXAS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. TEXAS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. INDONESIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. MALAYSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. PHILIPPINES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. SOUTH KOREA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. THAILAND SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. FRANCE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. ITALY SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. NETHERLANDS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. QATAR SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. RUSSIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. SAUDI ARABIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. SOUTH AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 167. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 168. SPAIN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 169. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 170. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 171. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 172. UNITED ARAB EMIRATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 173. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 174. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TESTING TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 175. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 176. UNITED KINGDOM SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 177. GLOBAL SEPSIS DIAGNOSTIC MARKET: SCORES
  • TABLE 178. GLOBAL SEPSIS DIAGNOSTIC MARKET: BUSINESS STRATEGY
  • TABLE 179. GLOBAL SEPSIS DIAGNOSTIC MARKET: PRODUCT SATISFACTION
  • TABLE 180. GLOBAL SEPSIS DIAGNOSTIC MARKET: RANKING
  • TABLE 181. GLOBAL SEPSIS DIAGNOSTIC MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 182. GLOBAL SEPSIS DIAGNOSTIC MARKET: SHARE, BY COMPANY, 2020
  • TABLE 183. GLOBAL SEPSIS DIAGNOSTIC MARKET: MERGER & ACQUISITION
  • TABLE 184. GLOBAL SEPSIS DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 185. GLOBAL SEPSIS DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 186. GLOBAL SEPSIS DIAGNOSTIC MARKET: INVESTMENT & FUNDING
  • TABLE 187. GLOBAL SEPSIS DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 188. GLOBAL SEPSIS DIAGNOSTIC MARKET: LICENSE & PRICING
  • TABLE 189. GLOBAL SEPSIS DIAGNOSTIC MARKET: CONTACT DETAILS